Convection‐Enhanced Drug Delivery to the Brain: Therapeutic Potential and Neuropathological Considerations

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Brain Pathology

• Publication date

  2014-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/bpa.12082PMID 23944716PMCID PMC8028869
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Robot-guided convection-enhanced delivery of carboplatin for advanced brainstem glioma

  2013influential reference
• GDNF, NGF and BDNF as therapeutic options for neurodegeneration.

  2013cited by this paper
• Intermittent convection-enhanced delivery to the brain through a novel transcutaneous bone-anchored port.

  2013cited by this paper
• In vitro and in vivo testing of a novel recessed-step catheter for reflux-free convection-enhanced drug delivery to the brain.

  2013influential reference
• Gene Transfer Corrects Acute GM2 Gangliosidosis-Potential Therapeutic Contribution of Perivascular Enzyme Flow.

  2012cited by this paper
• Widespread suppression of huntingtin with convection-enhanced delivery of siRNA.

  2012cited by this paper
• Atrophy of the cholinergic Basal forebrain over the adult age range and in early stages of Alzheimer's disease.

  2012cited by this paper
• Targeted delivery of nerve growth factor via encapsulated cell biodelivery in Alzheimer disease: a technology platform for restorative neurosurgery.

  2012cited by this paper
• Convection-Enhanced Delivery of Neprilysin: A Novel Amyloid-β-Degrading Therapeutic Strategy

  2012influential reference
• Influence of needle insertion speed on backflow for convection-enhanced delivery.

  2012cited by this paper
• Gene transfer corrects acute GM2 gangliosidosis--potential therapeutic contribution of perivascular enzyme flow.

  2012cited by this paper
• Convection-enhanced delivery of M13 bacteriophage to the brain.

  2012cited by this paper
• Intrastriatal convection-enhanced delivery results in widespread perivascular distribution in a pre-clinical model

  2012cited by this paper
• The development of an implantable catheter system for chronic or intermittent convection-enhanced delivery.

  2012influential reference
• Regression of Recurrent Malignant Gliomas With Convection-Enhanced Delivery of Topotecan

  2011cited by this paper
• T2 Imaging in Monitoring of Intraparenchymal Real-Time Convection-Enhanced Delivery

  2011cited by this paper
• Regression of recurrent glioblastoma infiltrating the brainstem after convection-enhanced delivery of nimustine hydrochloride.

  2011cited by this paper
• Colocalization of Gadolinium-Diethylene Triamine Pentaacetic Acid With High-Molecular-Weight Molecules After Intracerebral Convection-Enhanced Delivery in Humans

  2011cited by this paper
• Image-guided convection-enhanced delivery of GDNF protein into monkey putamen.

  2011cited by this paper
• A&bgr;-Degrading Enzymes: Potential for Treatment of Alzheimer Disease

  2011cited by this paper
• Tracking accuracy of T2- and diffusion-weighted magnetic resonance imaging for infusate distribution by convection-enhanced delivery.

  2011cited by this paper
• Optimal region of the putamen for image-guided convection-enhanced delivery of therapeutics in human and non-human primates.

  2011influential reference
• An evaluation of the relationships between catheter design and tissue mechanics in achieving high-flow convection-enhanced delivery.

  2011cited by this paper
• Convection-enhanced delivery to achieve widespread distribution of viral vectors: Predicting clinical implementation.

  2010cited by this paper
• Intracerebral administration of CpG oligonucleotide for patients with recurrent glioblastoma: a phase II study.

  2010cited by this paper
• Targeted therapy for high-grade glioma with the TGF-β2 inhibitor trabedersen: results of a randomized and controlled phase IIb study

  2010cited by this paper
• Effect of imaging and catheter characteristics on clinical outcome for patients in the PRECISE study

  2010cited by this paper
• Qualitative Imaging of Adeno-Associated Virus Serotype 2–Human Aromatic L-Amino Acid Decarboxylase Gene Therapy in a Phase I Study for the Treatment of Parkinson Disease

  2010cited by this paper
• Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma.

  2010cited by this paper
• Lentivirus-expressed siRNA vectors against Alzheimer disease.

  2010cited by this paper
• Poor drug distribution as a possible explanation for the results of the PRECISE trial.

  2010cited by this paper
• Optimized cannula design and placement for convection-enhanced delivery in rat striatum.

  2010cited by this paper
• Controlled dissemination of AAV vectors in the primate brain.

  2009cited by this paper
• ANATOMIC COMPRESSION CAUSED BY HIGH‐VOLUME CONVECTION‐ENHANCED DELIVERY TO THE BRAIN

  2009cited by this paper
• Safety and tolerability of putaminal AADC gene therapy for Parkinson disease

  2009cited by this paper
• Efficient gene therapy-based method for the delivery of therapeutics to primate cortex

  2009cited by this paper
• Convection-enhanced delivery of polyethylene glycol-coated liposomal doxorubicin: characterization and efficacy in rat intracranial glioma models.

  2008cited by this paper
• Neprilysin: an enzyme candidate to slow the progression of Alzheimer's disease.

  2008cited by this paper
• 188Re-loaded lipid nanocapsules as a promising radiopharmaceutical carrier for internal radiotherapy of malignant gliomas

  2008cited by this paper
• Long-term neprilysin gene transfer is associated with reduced levels of intracellular Abeta and behavioral improvement in APP transgenic mice

  2008cited by this paper
• Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease.

  2008cited by this paper
• HIV TAT peptide modifies the distribution of DNA nanolipoparticles following convection-enhanced delivery.

  2008cited by this paper
• Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: significance for cerebral amyloid angiopathy and neuroimmunology

  2008cited by this paper
• Convection-enhanced delivery of maghemite nanoparticles: Increased efficacy and MRI monitoring.

  2008cited by this paper
• Induction of hyperintense signal on T2-weighted MR images correlates with infusion distribution from intracerebral convection-enhanced delivery of a tumor-targeted cytotoxin.

  2007influential reference
• SYMPOSIUM: Clearance of Aβ from the Brain in Alzheimer's Disease: Perivascular Drainage of Amyloid‐β Peptides from the Brain and Its Failure in Cerebral Amyloid Angiopathy and Alzheimer's Disease

  2007cited by this paper
• Immune responses to adenovirus and adeno-associated vectors used for gene therapy of brain diseases: the role of immunological synapses in understanding the cell biology of neuroimmune interactions.

  2007cited by this paper
• Convective delivery of glial cell line-derived neurotrophic factor in the human putamen.

  2007cited by this paper
• Loss of neprilysin function promotes amyloid plaque formation and causes cerebral amyloid angiopathy.

  2007cited by this paper
• Point source concentration of GDNF may explain failure of phase II clinical trial.

  2006cited by this paper
• Unilateral intraputaminal glial cell line-derived neurotrophic factor in patients with Parkinson disease: response to 1 year each of treatment and withdrawal.

  2006cited by this paper
• Lack of neprilysin suffices to generate murine amyloid‐like deposits in the brain and behavioral deficit in vivo

  2006cited by this paper
• Tissue affinity of the infusate affects the distribution volume during convection-enhanced delivery into rodent brains: implications for local drug delivery.

  2006cited by this paper
• Randomized controlled trial of intraputamenal glial cell line–derived neurotrophic factor infusion in Parkinson disease

  2006cited by this paper
• The "perivascular pump" driven by arterial pulsation is a powerful mechanism for the distribution of therapeutic molecules within the brain.

  2006cited by this paper
• Neprilysin-sensitive Synapse-associated Amyloid-β Peptide Oligomers Impair Neuronal Plasticity and Cognitive Function*

  2006cited by this paper
• Inhibition of neprilysin by thiorphan (i.c.v.) causes an accumulation of amyloid beta and impairment of learning and memory.

  2006cited by this paper
• Inhibition of Neprilysin by Infusion of Thiorphan into the Hippocampus Causes an Accumulation of Amyloid β and Impairment of Learning and Memory

  2006cited by this paper
• Comparison of intratumoral bolus injection and convection-enhanced delivery of radiolabeled antitenascin monoclonal antibodies.

  2006influential reference
• Inhibition of neprilysin by thiorphan (i.c.v.) causes an accumulation of amyloid β and impairment of learning and memory

  2006cited by this paper
• Neuronal neprilysin overexpression is associated with attenuation of Abeta-related spatial memory deficit.

  2006cited by this paper
• AAV2-mediated gene delivery to monkey putamen: evaluation of an infusion device and delivery parameters.

  2005cited by this paper
• Intraputamenal infusion of glial cell line–derived neurotrophic factor in PD: A two‐year outcome study

  2005cited by this paper
• Reflux-free cannula for convection-enhanced high-speed delivery of therapeutic agents.

  2005cited by this paper
• Effects of the perivascular space on convection-enhanced delivery of liposomes in primate putamen.

  2005cited by this paper
• Surface properties, more than size, limiting convective distribution of virus-sized particles and viruses in the central nervous system.

  2005cited by this paper
• Glial cell line–derived neurotrophic factor induces neuronal sprouting in human brain

  2005cited by this paper
• A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease

  2005cited by this paper
• Distribution in brain of liposomes after convection enhanced delivery; modulation by particle charge, particle diameter, and presence of steric coating.

  2005influential reference
• Convection-enhanced delivery of paclitaxel for the treatment of recurrent malignant glioma: a phase I/II clinical study.

  2004cited by this paper
• Presynaptic Localization of Neprilysin Contributes to Efficient Clearance of Amyloid-β Peptide in Mouse Brain

  2004cited by this paper
• Neprilysin Gene Transfer Reduces Human Amyloid Pathology in Transgenic Mice

  2003cited by this paper
• Direct brain infusion of glial cell line–derived neurotrophic factor in Parkinson disease

  2003cited by this paper
• Heparin coinfusion during convection-enhanced delivery (CED) increases the distribution of the glial-derived neurotrophic factor (GDNF) ligand family in rat striatum and enhances the pharmacological activity of neurturin.

  2001cited by this paper
• Metabolic regulation of brain Abeta by neprilysin.

  2001cited by this paper
• Neprilysin Degrades Both Amyloid β Peptides 1–40 and 1–42 Most Rapidly and Efficiently among Thiorphan- and Phosphoramidon-sensitive Endopeptidases*

  2001cited by this paper
• Convection-enhanced delivery of AAV-2 combined with heparin increases TK gene transfer in the rat brain

  2001cited by this paper
• Metabolic Regulation of Brain Aβ by Neprilysin

  2001cited by this paper
• Identification of the major Aβ1–42-degrading catabolic pathway in brain parenchyma: Suppression leads to biochemical and pathological deposition

  2000cited by this paper
• Reply to: 'Clearance of amyloid β-peptide from brain: transport or metabolism?'

  2000cited by this paper
• The rates of the exchange reactions between [Gd(DTPA)]2- and the endogenous ions Cu2+ and Zn2+: a kinetic model for the prediction of the in vivo stability of [Gd(DTPA)]2-, used as a contrast agent in magnetic resonance imaging.

  2000cited by this paper
• Intratumoral administration of recombinant circularly permuted interleukin-4-Pseudomonas exotoxin in patients with high-grade glioma.

  2000cited by this paper
• Variables affecting convection-enhanced delivery to the striatum: a systematic examination of rate of infusion, cannula size, infusate concentration, and tissue-cannula sealing time.

  1999cited by this paper
• Focal delivery during direct infusion to brain: role of flow rate, catheter diameter, and tissue mechanics.

  1999cited by this paper
• Platinum distribution in malignant glioma following intraoperative intravenous infusion of carboplatin.

  1999cited by this paper
• Delivery, Distribution, and Neuronal Uptake of Exogenous Mannose-Terminal Glucocerebrosidase in the Intact Rat Brain

  1999cited by this paper
• Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease.

  1998cited by this paper
• Perivascular spaces in the basal ganglia of the human brain: their relationship to lacunes

  1997influential reference
• Increasing volume of distribution to the brain with interstitial infusion: dose, rather than convection, might be the most important factor.

  1996cited by this paper
• Convection-enhanced distribution of large molecules in gray matter during interstitial drug infusion.

  1995cited by this paper
• High-flow microinfusion: tissue penetration and pharmacodynamics.

  1994cited by this paper
• Convection-enhanced delivery of macromolecules in the brain.

  1994cited by this paper
• Distribution of extracellular tracers in perivascular spaces of the rat brain.

  1991cited by this paper
• Rapid solute transport throughout the brain via paravascular fluid pathways.

  1990cited by this paper
• Interrelationships of the pia mater and the perivascular (Virchow-Robin) spaces in the human cerebrum.

  1990cited by this paper
• The Cranial Arachnoid and Pia Mater in Man: Anatomical and Ultrastructural Observations

  1988cited by this paper
• Anatomical relationships of the pia mater to cerebral blood vessels in man.

  1986cited by this paper
• Evidence for a 'paravascular' fluid circulation in the mammalian central nervous system, provided by the rapid distribution of tracer protein throughout the brain from the subarachnoid space.

  1985cited by this paper
• A method for microscopic studies of cerebral angioarchitecture and vascular-parenchymal relationships, based on the demonstration of 'paravascular' fluid pathways in the mammalian central nervous system.

  1985cited by this paper
• Drainage of interstitial fluid from different regions of rat brain.

  1984cited by this paper

• Segmentation and structural connectivity of the putamen for targeted convection enhanced drug delivery in Parkinson’s disease: a tractography-based approach

  2026cites this paper
• Robot-assisted intrathalamic infusion for gene therapy in young children: surgical considerations.

  2025cites this paper
• Digital Twin Technology In Radiology.

  2025cites this paper
• Drug delivery strategies for paediatric diffuse midline gliomas.

  2025cites this paper
• Enhancing adoptive cell therapy: future strategies for immune cell radioprotection in neuro-oncology

  2025cites this paper
• Clinical translation of nanomedicines for brain diseases: Current challenges and future directions.

  2025cites this paper
• Pharmacological Phase I Clinical Trials in Pediatric Brain Tumors (1990–2024): A Historical Perspective

  2025cites this paper
• Convection-enhanced delivery for brain malignancies: Technical parameters, formulation strategies and clinical perspectives.

  2025cites this paper
• Intranasal administration of temozolomide conjugated nanoparticles with transcranial magnetic stimulation improves the survival in glioblastoma xenograft models

  2025cites this paper
• Infusion and iontophoresis for directional delivery of compounds to the brain

  2025cites this paper
• Utilization of nanotechnology to surmount the blood-brain barrier in disorders of the central nervous system

  2025cites this paper
• Smart Bioelectronics for Real-Time Diagnosis and Therapy of Body Organ Functions.

  2025cites this paper
• Overview of the Current Knowledge and Conventional MRI Characteristics of Peri- and Para-Vascular Spaces

  2024cites this paper
• Neuropathological Findings in Nonclinical Species Following Administration of Adeno-Associated Virus (AAV)-Based Gene Therapy Vectors

  2024cites this paper
• Intra-arterial administration of PSMA-targeted radiopharmaceuticals for brain tumors: is the era of interventional theranostics next?

  2024cites this paper
• Recent Advances in Drug Delivery Systems for Targeting the Blood-Brain Barrier

  2024cites this paper
• Neurological insights into brain-targeted cancer therapy and bioinspired microrobots.

  2024cites this paper
• Recombinant Adeno-Associated Virus Vectors for Gene Therapy of the Central Nervous System: Delivery Routes and Clinical Aspects

  2024cites this paper
• Dose-Ranging Effects of the Intracerebral Administration of Atsttrin in Experimental Model of Parkinson’s Disease Induced by 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in Mice

  2024cites this paper
• Recent advances in targeted drug delivery for the treatment of glioblastoma.

  2024cites this paper
• Dopaminergic Cell Replacement for Parkinson’s Disease: Addressing the Intracranial Delivery Hurdle

  2024cites this paper
• Implantable theranostic device for in vivo real-time NMR evaluation of drug impact in brain tumors

  2024cites this paper
• Convection-enhanced Diffusion: A Novel Tactics to Crack the BBB.

  2024cites this paper
• Nanoparticle-based drug delivery across the blood-brain barrier for treating malignant brain glioma

  2023cites this paper
• Controlled electroactive release from solid-state conductive elastomer electrodes

  2023cites this paper
• Self-delivering, chemically modified CRISPR RNAs for AAV co-delivery and genome editing in vivo

  2023cites this paper
• A Biphasic Fluid-Structure Interaction Model of Backflow During Infusion Into Agarose Gel.

  2023cites this paper
• Peptide-Based Agents for Cancer Treatment: Current Applications and Future Directions

  2023cites this paper
• Intraparenchymal convection enhanced delivery of AAV in sheep to treat Mucopolysaccharidosis IIIC

  2023cites this paper
• Fifty years of DIPG: looking at the future with hope

  2023cites this paper
• PNOC015: Repeated convection enhanced delivery (CED) of MTX110 (aqueous panobinostat) in children with newly diagnosed diffuse intrinsic pontine glioma (DIPG).

  2023cites this paper
• Miniaturized neural implants for localized and controllable drug delivery in the brain.

  2023cites this paper
• Overcoming translational barriers in H3K27-altered diffuse midline glioma: Increasing the drug-tumor residence time

  2023cites this paper
• Self-delivering CRISPR RNAs for AAV Co-delivery and Genome Editing in vivo

  2023cites this paper
• The peculiar challenge of bringing CAR-T cells into the brain: Perspectives in the clinical application to the treatment of pediatric central nervous system tumors

  2023cites this paper
• Childhood Brain Tumors: A Review of Strategies to Translate CNS Drug Delivery to Clinical Trials

  2023cites this paper
• An in vivo Cell-Based Delivery Platform for Zinc Finger Artificial Transcription Factors in Pre-clinical Animal Models

  2022cites this paper
• Smart Nanoformulations for Brain Cancer Theranostics: Challenges and Promises

  2022cites this paper
• Getting drugs to the brain: advances and prospects of organic nanoparticle delivery systems for assisting drugs to cross the blood-brain barrier.

  2022cites this paper
• Numerical analysis of a porous-elastic model for convection enhanced drug delivery

  2022cites this paper
• A systematic review on intra-arterial cerebral infusions of chemotherapeutics in the treatment of glioblastoma multiforme: The state-of-the-art

  2022cites this paper
• Convection-Enhanced Delivery of Antiangiogenic Drugs and Liposomal Cytotoxic Drugs to Heterogeneous Brain Tumor for Combination Therapy

  2022cites this paper
• Lipid nanoparticles strategies to modify pharmacokinetics of central nervous system targeting drugs: crossing or circumventing the blood-brain barrier (BBB) to manage neurological disorders.

  2022cites this paper
• Infusion of Therapeutic Agents to the Brain (Convection-Enhanced Intraparenchymal Delivery)

  2022cites this paper
• Glioblastoma: Current Status, Emerging Targets, and Recent Advances

  2022cites this paper
• Nanotherapeutic treatment of the invasive glioblastoma tumor microenvironment.

  2022cites this paper
• In-vitro and In-vivo performance studies of a porous infusion catheter designed for intraparenchymal delivery of therapeutic agents of varying size.

  2022cites this paper
• Integrating mechanism-based modeling with biomedical imaging to build practical digital twins for clinical oncology.

  2022cites this paper
• Co-encapsulation of Cas9 mRNA and guide RNA in polyplex micelles enables genome editing in mouse brain.

  2021cites this paper
• Multifunctional lipidic nanocarriers for effective therapy of glioblastoma: recent advances in stimuli-responsive, receptor and subcellular targeted approaches

  2021cites this paper
• Multifunctional lipidic nanocarriers for effective therapy of glioblastoma: recent advances in stimuli-responsive, receptor and subcellular targeted approaches

  2021cites this paper
• Transportation of Single-Domain Antibodies through the Blood–Brain Barrier

  2021cites this paper
• Neuroprotective effect of magnesium supplementation on cerebral ischemic diseases.

  2021cites this paper
• Recent advances in the design of inorganic and nano-clay particles for the treatment of brain disorders.

  2021cites this paper
• Pectic Galactan Polysaccharide‐Based Gene Delivery System for Targeting Neuroinflammation

  2021cites this paper
• Injectable Glycosaminoglycan-Based Cryogels from Well-Defined Microscale Templates for Local Growth Factor Delivery

  2021cites this paper
• Transferrin Receptor-Targeted PEG-PLA Polymeric Micelles for Chemotherapy Against Glioblastoma Multiforme

  2020cites this paper
• Novel therapeutics for brain tumors: current practice and future prospects

  2020cites this paper
• The Interstitial System of the Brain in Health and Disease

  2020cites this paper
• Amphetamine decorated cationic lipid nanoparticles cross the blood-brain barrier: therapeutic promise for combating glioblastoma.

  2020cites this paper
• Computationally Guided Intracerebral Drug Delivery via Chronically Implanted Microdevices.

  2020cites this paper
• Advances in drug delivery technology for the treatment of glioblastoma multiforme.

  2020cites this paper
• Mechanical characterization of a fiberoptic microneedle device for controlled delivery of fluids and photothermal excitation.

  2020cites this paper
• Surgical methodology and protocols for preventing implanted cerebral catheters from becoming obstructed during and after neurosurgery.

  2020cites this paper
• The 100 most-cited articles about convection-enhanced delivery to the brain: a bibliometric analysis.

  2019cites this paper
• Nanotherapeutic strategies for the treatment of neurodegenerative diseases

  2019cites this paper
• The Advances of Biomacromolecule-based Nanomedicine in Brain Disease

  2019cites this paper
• Liposome-based targeted delivery of anticancer drugs for effective therapy of brain tumors

  2019cites this paper
• Improving the Brain Delivery of Chemotherapeutic Drugs in Childhood Brain Tumors

  2019cites this paper
• Solid Lipid Nanoparticles for Brain Targeting

  2019cites this paper
• Convection-enhanced Drug Delivery for Glioblastoma: A Systematic Review Focused on Methodological Differences in the Use of the Convection-enhanced Delivery Method

  2019influential citation
• A Long Short-Term Memory Network for Vessel Reconstruction Based on Laser Doppler Flowmetry via a Steerable Needle

  2019cites this paper
• Convection-Enhanced Intraparenchymal Delivery of Drugs to the Brain

  2019cites this paper
• Convection-enhanced delivery of cetuximab conjugated iron-oxide nanoparticles for treatment of spontaneous canine intracranial gliomas

  2018cites this paper
• Exploiting Botulinum Neurotoxins for the Study of Brain Physiology and Pathology

  2018cites this paper
• Improving the Predictions of Computational Models of Convection-Enhanced Drug Delivery by Accounting for Diffusion Non-gaussianity

  2018cites this paper
• Harnessing the immune system in glioblastoma

  2018cites this paper
• Altered Tracer Distribution and Clearance in the Extracellular Space of the Substantia Nigra in a Rodent Model of Parkinson's Disease

  2017cites this paper
• Using Computed Tomography Perfusion to Evaluate the Blood-Brain-Barrier and Blood-Tumor-Barrier Response following Focused Ultrasound Sonication with Microbubble Administration

  2017cites this paper
• Systems-level thinking for nanoparticle-mediated therapeutic delivery to neurological diseases.

  2017cites this paper
• The brain interstitial system: Anatomy, modeling, in vivo measurement, and applications

  2017cites this paper
• Diagnosis and Drug Delivery to the Brain

  2017cites this paper
• Repurposing the anti-epileptic drug sodium valproate as an adjuvant treatment for diffuse intrinsic pontine glioma

  2017cites this paper
• Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma.

  2017cites this paper
• Effective Drug Delivery in Diffuse Intrinsic Pontine Glioma: A Theoretical Model to Identify Potential Candidates

  2017cites this paper
• Liposomal temozolomide drug delivery using convection enhanced delivery

  2017cites this paper
• A Review on Liposomes and Polymeric Nanoparticles as Drug Delivery Vehicles to the Brain

  2017cites this paper
• Convection enhanced delivery of panobinostat (LBH589)-loaded pluronic nano-micelles prolongs survival in the F98 rat glioma model

  2017cites this paper
• Recent Advances in Preclinical Studies and Potential Applications of Dendrimers as Drug Carriers in the Central Nervous System.

  2017cites this paper
• Angiopep-2-conjugated poly(ethylene glycol)-co- poly(ε-caprolactone) polymersomes for dual-targeting drug delivery to glioma in rats

  2017cites this paper
• Exosomes as Tools to Suppress Primary Brain Tumor

  2016cites this paper
• Drug Repurposing to Circumvent Chemotherapy Resistance in Brain Tumours

  2016cites this paper
• Peking University - Juntendo University Joint Symposium on Brain and Skin Diseases Rare Fungal Infections: What Should We Know?

  2016cites this paper
• School in Nanostructure and Nanotechnologies XXVIII Cycle Enhanced Brain Targeting of ApoE – functionalized Lipid Nanoparticles

  2016cites this paper
• Peking University - Juntendo University Joint Symposium on Brain and Skin Diseases Measurement of the Brain Extracellular Space Using Tracer-Based MRI

  2016cites this paper
• Safety Evaluation of CNS Administered Biologics-Study Design, Data Interpretation, and Translation to the Clinic.

  2016cites this paper
• Targeting delivery in Parkinson's disease.

  2016cites this paper
• Juntendo Medical Journal

  2016cites this paper
• Strategies for improving the intratumoral distribution of liposomal drugs in cancer therapy

  2016cites this paper
• Application of Convection-Enhanced Drug Delivery in the Treatment of Malignant Gliomas.

  2016cites this paper